GILEAD SCIENCES
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.
GILEAD SCIENCES
Industry:
Biopharma Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1987-06-22
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.gilead.com
Total Employee:
10001+
Status:
Active
Contact:
650-574-3000
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Aerogen, Inc.
Aerogen, Inc. operates as a specialty pharmaceutical company that develops, manufactures, and commercializes pulmonary.
Apotex Inc.
APOTEX is a pharmaceutical company committed to R&D, affordable medicines to patients.
BTG Specialty Pharmaceuticals
BTG Specialty Pharmaceuticals develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings.
Charles River Laboratories International
Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Eli Lilly
Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients.
HyperbaricLink
HyperbaricLink is a web guide to hyperbaric oxygen therapy, an FDA-approved medical treatment for specific diseases.
IMA Group
IMA design and manufacture of automatic machines for the processing and packaging of pharmaceuticals.
Ipsen
Ipsen develops and markets medications used in oncology, neuroscience and rare diseases along with consumer healthcare products.
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Libertas Pharma
Libertas Pharma a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceutical products.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Meijer
Meijer is a shopping website for grocery, health, and beauty care.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
The Stevanato Group
Stevanato Group S.p.A. manufactures packaging containers from glass tubing for the pharmaceutical industry worldwide.
Vion Pharmaceuticals Inc
Vion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes cancer treatment technologies.
Zimmer Biomet
Zimmer Biomet designs, develops, manufactures, and markets orthopedic reconstructive and spinal products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-08-04 | MiroBio | MiroBio acquired by Gilead Sciences | 405 M USD |
| 2020-12-10 | MYR GmbH | MYR GmbH acquired by Gilead Sciences | 1.45 B EUR |
| 2020-09-13 | Immunomedics | Immunomedics acquired by Gilead Sciences | 21 B USD |
| 2020-03-02 | Forty Seven | Forty Seven acquired by Gilead Sciences | 4.9 B USD |
| 2017-12-07 | Cell Design Labs | Cell Design Labs acquired by Gilead Sciences | 567 M USD |
| 2017-08-28 | Kite Pharma | Kite Pharma acquired by Gilead Sciences | 11.9 B USD |
| 2016-04-04 | Nimbus Apollo | Nimbus Apollo acquired by Gilead Sciences | N/A |
| 2015-05-06 | Epitherapeutics | Epitherapeutics acquired by Gilead Sciences | 65 M USD |
| 2015-01-06 | Phenex Pharmaceuticals | Phenex Pharmaceuticals acquired by Gilead Sciences | 470 M USD |
| 2013-02-08 | YM BioSciences | YM BioSciences acquired by Gilead Sciences | 487.6 M USD |
Investors List
Venrock
Venrock investment in Seed Round - Gilead Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | AlloVir | Gilead Sciences investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2022-05-23 | Exavir Therapeutics | Gilead Sciences investment in Seed Round - Exavir Therapeutics | 4 M USD |
| 2022-05-05 | Curebase | Gilead Sciences investment in Series B - Curebase | 40 M USD |
| 2022-01-26 | Kyverna Therapeutics | Gilead Sciences investment in Series B - Kyverna Therapeutics | 85 M USD |
| 2021-12-27 | Pardes Biosciences | Gilead Sciences investment in Post-IPO Equity - Pardes Biosciences | 75 M USD |
| 2021-11-16 | Destination Tomorrow | Gilead Sciences investment in Grant - Destination Tomorrow | 1000 K USD |
| 2021-09-16 | Gritstone Bio | Gilead Sciences investment in Post-IPO Equity - Gritstone Bio | 55 M USD |
| 2021-08-11 | Tango Therapeutics | Gilead Sciences investment in Post-IPO Equity - Tango Therapeutics | 186 M USD |
| 2021-06-24 | Lyndra Therapeutics | Gilead Sciences investment in Series C - Lyndra Therapeutics | 60.5 M USD |
| 2021-03-17 | Vaccitech | Gilead Sciences investment in Series B - Vaccitech | 168 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.gilead.com Semrush global rank: 227.01 K Semrush visits lastest month: 319.31 K
- Host name: 40.70.27.35
- IP address: 40.70.27.35
- Location: Boydton United States
- Latitude: 36.6534
- Longitude: -78.375
- Metro Code: 560
- Timezone: America/New_York
- Postal: 23917
